Tempus AI, Inc. Class A Common Stock (TEM)

Tempus AI, Inc. Class A (TEM) is a technology company focused on developing artificial intelligence-driven solutions. It specializes in leveraging AI to improve efficiency and decision-making in various industries, including finance, healthcare, and enterprise services. The company aims to deliver innovative software and data analytics tools to enhance business operations and insights.

Dividend Yield 0.29%
Payout Frequency Yearly

Dividend History

Pay Date Amount Ex-Date Record Date
July 28, 2006 $0.26 2006-07-18 2006-07-20
July 28, 2006 $0.44 2006-07-18 2006-07-20
June 22, 2005 $0.23 2005-06-10 2005-06-14
June 28, 2004 $0.22 2004-06-21 2004-06-23
June 26, 2003 $0.20 2003-06-16 2003-06-18

Dividends Summary

Company News

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
Benzinga • Prnewswire • September 18, 2025

The global cell therapy market is projected to grow from $5.88 billion in 2024 to $44.39 billion by 2034, driven by rising demand for regenerative medicine, advancements in biotechnology, and increasing prevalence of chronic diseases.

Why Tempus AI Stock Soared Nearly 14% Higher Today
The Motley Fool • Eric Volkman • September 11, 2025

Tempus AI's stock rose nearly 14% after receiving FDA clearance for an upgraded Tempus Pixel cardiac imaging platform that leverages AI technology to produce highly accurate heart images.

Top Short-Interest Stocks to Buy Before November
Investing.com • Thomas Hughes • August 20, 2025

The article highlights five high short-interest stocks with strong AI and technology fundamentals that are expected to report Q3 results in November, showing potential for market-leading growth and improving shareholder value.

TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • August 14, 2025

Law firm investigating potential claims against Tempus AI for alleged breaches of fiduciary duties, including inflated contract values, questionable business practices, and misleading financial reporting, following a Spruce Point Capital Management report.

AZN